A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies
Juric, Dejan, de Bono, Johann S, LoRusso, Patricia M, Nemunaitis, John, Heath, Elisabeth I, Kwak, Eunice L, Macarulla Mercadé, Teresa, Geuna, Elena, Jose de Miguel-Luken, Maria, Patel, Chirag, Kuida, Keisuke, Sankoh, Serap, Westin, Eric H, Zohren, Fabian, Shou, Yaping, Tabernero, Josep
Published in Clinical cancer research (01.09.2017)
Published in Clinical cancer research (01.09.2017)
Get full text
Journal Article
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study
Gkika, Eleni, Grosu, Anca-Ligia, Macarulla Mercade, Teresa, Cubillo Gracián, Antonio, Brunner, Thomas B, Schultheiß, Michael, Pazgan-Simon, Monika, Seufferlein, Thomas, Touchefeu, Yann
Published in Cancers (18.03.2022)
Published in Cancers (18.03.2022)
Get full text
Journal Article
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
Qin, Shukui, Finn, Richard S, Kudo, Masatoshi, Meyer, Tim, Vogel, Arndt, Ducreux, Michel, Macarulla, Teresa Mercade, Tomasello, Gianluca, Boisserie, Frederic, Hou, Jeannie, Li, Xin, Song, James, Zhu, Andrew X
Published in Future oncology (London, England) (01.06.2019)
Published in Future oncology (London, England) (01.06.2019)
Get full text
Journal Article
Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial
Macarulla Mercadé, Teresa, Chen, Li-Tzong, Li, Chung-Pin, Siveke, Jens T, Cunningham, David, Bodoky, György, Blanc, Jean-Frédéric, Lee, Kyung-Hun, Dean, Andrew, Belanger, Bruce, Wang-Gillam, Andrea
Published in Pancreas (01.01.2020)
Published in Pancreas (01.01.2020)
Get more information
Journal Article
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C
Almhanna, Khaldoun, Wright, David, Mercade, Teresa Macarulla, Van Laethem, Jean-Luc, Gracian, Antonio Cubillo, Guillen-Ponce, Carmen, Faris, Jason, Lopez, Carolina Muriel, Hubner, Richard A., Bendell, Johanna, Bols, Alain, Feliu, Jaime, Starling, Naureen, Enzinger, Peter, Mahalingham, Devalingham, Messersmith, Wells, Yang, Huyuan, Fasanmade, Adedigbo, Danaee, Hadi, Kalebic, Thea
Published in Investigational new drugs (01.10.2017)
Published in Investigational new drugs (01.10.2017)
Get full text
Journal Article
New Targets and New Drug Development in Colorectal Cancer
Garrido-Castro, Ana C., Sauri-Nadal, Tamara, Macarulla-Mercadé, Teresa
Published in Current colorectal cancer reports (01.09.2014)
Published in Current colorectal cancer reports (01.09.2014)
Get full text
Journal Article
Abstract CT117: A phase II trial of TAK-264, a novel antibody-drug conjugate (ADC), in patients with pancreatic adenocarcinoma expressing guanylyl cyclase C (GCC)
Almhanna, Khaldoun, Wright, David, Macarulla Mercadé, Teresa, Van Laethem, Jean-Luc, Cubillo Gracian, Antonio, Guillén-Ponce, Carmen, Faris, Jason, Muriel Lopez, Carolina, Hubner, Richard, Bendell, Johanna, Bols, Alain, Feliú Batlle, Jaime, Starling, Naureen, Enzinger, Peter, Mahalingham, Devalingham, Messersmith, Wells, Yang, Huyuan, Fasanmade, Adedigbo, Danaee, Hadi, Kalebic, Thea
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Results from the pivotal phase (Ph) 2b HERIZON-BTC-01 study: Zanidatamab in previously-treated HER2-amplified biliary tract cancer (BTC)
Pant, Shubham, Fan, Jia, Oh, Do-Youn, Choi, Hye Jin, Kim, Jin Won, Chang, Heung-Moon, Bao, Lequn, Sun, Hui-Chuan, Macarulla Mercade, Teresa, Xie, Feng, Metges, Jean Philippe, Jieer, Ying, Bridgewater, John A, Tejani, Mohamedtaki Abdulaziz, Chen, Emerson Yu-sheng, Wasan, Harpreet Singh, Ducreux, Michel Pierre, Ma, Jia-Fang, Garfin, Phillip M., Harding, James J.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A randomized phase II study of second-line treatment with liposomal irinotecan, and S-1 versus liposomal irinotecan and 5-fluorouracil in gemcitabine-refractory metastatic pancreatic cancer patients
Pijnappel, Esther, Vos-Geelen, Judith de, Macarulla Mercade, Teresa, Melisi, Davide, Pfeiffer, Per, Prager, Gerald W., Van Laarhoven, Hanneke W.M., Wilmink, Johanna
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis
Rimini, Margherita, Macarulla, Teresa Mercade, Burgio, Valentina, Lonardi, Sara, Niger, Monica, Scartozzi, Mario, Raposelli, Ilario, Aprile, Giuseppe, Ratti, Francesca, Pedica, Federica, Verdaguer, Helena, Nappo, Floriana, Nichetti, Federico, Lai, Eleonora, Valgiusti, Martina, Cappetta, Alessandro, Fabregat, Carles, Fassan, Matteo, De Braud, Filippo, Puzzoni, Marco, Frassineti, Giovanni Luca, Simionato, Francesca, De Cobelli, Francesco, Aldrighetti, Luca, Fornaro, Lorenzo, Cascinu, Stefano, Gardini, Andrea Casadei
Published in Journal of hepatology (01.07.2022)
Published in Journal of hepatology (01.07.2022)
Get full text
Journal Article
Molecular profile of ampulla of vater carcinoma (AVC): A rare tumor type with meaningful molecular alterations
Pinto, João, Verdaguer, Helena, Salcedo, Maria Teresa, Pedrola, Anna, Hernando-Cubero, Jorge, Pastrana, Juan David Assaf, Acosta, Daniel, Vivancos, Ana, Dienstmann, Rodrigo, Mercade, Teresa Macarulla
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Geographic and ethnic heterogeneity in the BRCA1/2 pre-screening population for the randomized phase III POLO study of olaparib maintenance in metastatic pancreatic cancer (mPC)
Golan, Talia, Kindler, Hedy L., Park, Joon Oh, Reni, Michele, Mercade, Teresa Macarulla, Hammel, Pascal, Van Cutsem, Eric, Arnold, Dirk, Hochhauser, Daniel, Locker, Gershon Y., Hall, Michael J.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Translating molecular subtypes of gastric and gastroesophageal junction cancer (GC and GEJC) to the metastatic (met) setting: Prevalence and outcome dataTranslating molecular subtypes of gastric and gastroesophageal junction cancer (GC and GEJC) to the metastatic (met) setting: prevalence and outcome data
Gardeazabal, Itziar, Hierro, Cinta, Viaplana, Cristina, Nuciforo, Paolo, Vivancos, Ana, Mercade, Teresa Macarulla, Garralda, Elena, Semidey, Maria Eugenia, Grau Bejar, Juan Francisco, Dienstmann, Rodrigo, Landolfi, Stefania, Alsina, Maria
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Phase 1b multi-indication study of the antibody drug conjugate anetumab ravtansine in patients with mesothelin-expressing advanced or recurrent malignancies
Adjei, Alex A., Bekaii-Saab, Tanios S., Berlin, Jordan, Philip, Philip Agop, Mercade, Teresa Macarulla, Walter, Annette, Cupit, Lisa, Liu, Rong, Fields, Scott Z., Holynskyj, Ariadna
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase 3 study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial
Javle, Milind M., Borbath, Ivan, Clarke, Stephen John, Hitre, Erika, Louvet, Christophe, Mercade, Teresa Macarulla, Oh, Do-Youn, Spratlin, Jennifer L., Valle, Juan W., Weiss, Karl Heinz, Berman, Craig, Howland, Michael, Ye, Yining, Cho, Terry, Moran, Susan, Abou-Alfa, Ghassan K.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Impact of cholangiocarcinoma (CC) molecular heterogeneity on outcome during first-line chemotherapy and access to targeted therapies in early clinical trials (CT)
Verdaguer, Helena, Brana, Irene, Hierro, Cinta, Azaro, Analia, Elez, Elena, Garralda, Elena, Laquente, Berta, Grau Bejar, Juan Francisco, Ruiz-Pace, Fiorella, Viaplana, Cristina, Aguilar, Susana, Dienstmann, Rodrigo, Mercade, Teresa Macarulla
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Real-world data on overall survival (OS) impact of anti-EGFR sequence in patients (pts) with microsatellite stable (MSS) all-RAS and BRAF V600E wild-type metastatic (met) colorectal cancer (CRC)
Elez, Elena, Argiles, Guillem, Comas, Raquel, Garcia, Ariadna, Mulet, Nuria, Noguerido, Alba, Capdevila, Jaume, Matos, Ignacio, Martini, Giulia, Grau Bejar, Juan Francisco, Villacampa, Guillermo, Nuciforo, Paolo, Hernandez-Losa, Javier, Landolfi, Stefania, Vivancos, Ana, Mercade, Teresa Macarulla, Tabernero, Josep, Dienstmann, Rodrigo
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A phase 3, randomized, open-label, multicenter study to compare the efficacy and safety of tislelizumab, an anti-PD-1 antibody, versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma
Qin, Shukui, Finn, Richard S., Kudo, Masatoshi, Meyer, Tim, Vogel, Arndt, Ducreux, Michel, Mercade, Teresa Macarulla, Tomasello, Gianluca, Boisserie, Frederic, Hou, Jeannie, Li, Cindy, Song, James, Zhu, Andrew X.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
Kindler, Hedy L., Hammel, Pascal, Reni, Michele, Van Cutsem, Eric, Mercade, Teresa Macarulla, Hall, Michael J., Park, Joon Oh, Hochhauser, Daniel, Arnold, Dirk, Oh, Do-Youn, Reinacher-Schick, Anke C., Tortora, Giampaolo, Algül, Hana, O'Reilly, Eileen Mary, McGuinness, David, Cui, Karen, Schlienger, Katia, Locker, Gershon Y., Golan, Talia
Published in Journal of clinical oncology (20.06.2019)
Published in Journal of clinical oncology (20.06.2019)
Get full text
Journal Article
A phase Ib dose-escalation and cohort-expansion study of safety and activity of the transforming growth factor (TGF) β receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
Melisi, Davide, Hollebecque, Antoine, Oh, Do-Youn, Calvo, Emiliano, Varghese, Anna M., Borazanci, Erkut Hasan, Mercade, Teresa Macarulla, Simionato, Francesca, Park, Joon Oh, Bendell, Johanna C., Faivre, Sandrine J., Zhao, Yumin, Gueorguieva, Ivelina, Man, Michael, Estrem, Shawn, Benhadji, Karim Adnane, Lanasa, Mark, Guba, Susan C., Garcia-Carbonero, Rocio
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article